Indication:Management of type 2 diabetes mellitus.Dosage & Administration:Dose of this combination should be individualized on the basis of the patient’s current regimen, effectiveness, and tolerability while not exceeding the maximum recommended daily dose of 100 mg Sitagliptin and 2000 mg Metformi..
Indication:Management of type 2 diabetes mellitus.Dosage & Administration:Dose of this combination should be individualized on the basis of the patient’s current regimen, effectiveness, and tolerability while not exceeding the maximum recommended daily dose of 100 mg Sitagliptin and 2000 mg Metformi..
Sitagliptin phosphate INN equivalent to sitagliptin 50mg & 100mg/tablet.100mg x 10’s pack: 300.0Indication:Management of type 2 diabetes mellitus.Dosage & Administration:The recommended dose of Siglita™ is 100 mg once daily. Siglita™ can be taken with or without food.For patients with mild..
Sitagliptin phosphate INN equivalent to sitagliptin 50mg & 100mg/tablet.50mg x 10’s pack: 180.00Indication:Management of type 2 diabetes mellitus.Dosage & Administration:The recommended dose of Siglita™ is 100 mg once daily. Siglita™ can be taken with or without food.For patients with mild..
Glipita M 50/1000 tabletWhat is Glipita-M?Glipita-M is the preparation of sitagliptin and metformin. Sitagliptin phosphate, a dipeptidyl peptidase 4(DPP-4) inhibitor and metformin HCI, a member of the biguanide class. Glipita-M is indicated as an adjunct to diet and exercise to treat Type 2 diabetes..
What is Glipita-M?Glipita-M is the preparation of sitagliptin and metformin. Sitagliptin phosphate, a dipeptidyl peptidase 4(DPP-4) inhibitor and metformin HCI, a member of the biguanide class. Glipita-M is indicated as an adjunct to diet and exercise to treat Type 2 diabetes where metfromin is not ..
Sitagil M 50/1000 ER Tab.DescriptionSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which exerts its action by slowing the inactivation of incretin hormones. Incretin hormones, including glucagon-like peptide-1(GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), are released by..
Sitagil M 50/500 ER TabDescriptionSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which exerts its action by slowing the inactivation of incretin hormones. Incretin hormones, including glucagon-like peptide-1(GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), are released by t..
What is Glipita?Glipita is the preparation of Sitagliptin. Sitagliptin is a new oral agent approved by the USFDA to treat type 2 diabetes with diet & exercise. It belongs to a new class of antihyperglycemic, Dipeptidyl Dipeptidase-4 (DPP-4) inhibitors. This unique class of orally active agent target..
Glipita 50 tabletWhat is Glipita?Glipita is the preparation of Sitagliptin. Sitagliptin is a new oral agent approved by the USFDA to treat type 2 diabetes with diet & exercise. It belongs to a new class of antihyperglycemic, Dipeptidyl Dipeptidase-4 (DPP-4) inhibitors. This unique class of orally ac..
Indication:Management of type 2 diabetes mellitus.Dosage & Administration:The recommended dose of Siglita™ is 100 mg once daily. Siglita™ can be taken with or without food.For patients with mild renal insufficiency (creatinine clearance [CrCl] 50 mL/min) no dosage adjustment for Siglita™&n..
Indication:Management of type 2 diabetes mellitus.Dosage & Administration:The recommended dose of Siglita™ is 100 mg once daily. Siglita™ can be taken with or without food.For patients with mild renal insufficiency (creatinine clearance [CrCl] 50 mL/min) no dosage adjustment for Siglita™&n..